Incidence and Outcomes Associated With the Management of Adenovirus Infections in Allogenic Hematopoietic Cell Transplant Recipients
NCT04285788 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 216
Last updated 2022-03-25
Summary
To depict the incidence, outcomes and standards of care (SoC) of adenovirus (AdV) infections and associated practice patterns in allogeneic hematopoietic cell transplant recipients. It is expected that participating centers will be in the United Kingdom, France, Spain, Germany, and Italy.
Conditions
- Adenovirus Infections, Human
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 0 Months
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2015-09-30
- Completion
- 2017-01-31
More Related Trials
-
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
NCT01890486 ·Status: RECRUITING
-
Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study
NCT04372524 ·Status: RECRUITING
-
A Pilot Study of the Feasibility of Setting up a Logbook for Allogeneic Haematopoietic Stem Cell Patients at the University Hospital of Amiens
NCT03149952 ·Status: WITHDRAWN ·Phase: NA
-
Retrospective Study of Viral Reactivation Across All Bone Marrow Transplant Protocols Since 2010
NCT03111745 ·Status: COMPLETED
-
Cytomegalovirus Infection After HSCT and PT-CY as GVHD Prophylaxis >> GVHD PROPHYLAXIS ERA
NCT05315882 ·Status: COMPLETED
-
Study in Adult and Pediatric Patients With HSCT-TMA
NCT04970004 ·Status: WITHDRAWN
-
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
NCT04098445 ·Status: RECRUITING
-
Study of the Complications Associated With Certain Stem Cell Transplants
NCT01919099 ·Status: COMPLETED
-
Study of Adoptive Immunotherapy With Donor-derived CMV-specific T Cells for Recipients of Allo-HSCT
NCT02988258 ·Status: SUSPENDED ·Phase: PHASE1
-
Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
NCT00003538 ·Status: COMPLETED ·Phase: NA
-
Study of Non-Myeloablative Haplo-identical Haematopoietic Stem Cell Transplantation in Patients With Haematological Malignancies or Acquired Aplastic Anaemia
NCT01719341 ·Status: UNKNOWN
-
Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes
NCT03532971 ·Status: COMPLETED
-
Pulmonary Complications of Allografts
NCT01219972 ·Status: COMPLETED
-
Blood Virome After Haploidentical Hematopoietic Stem Cell Transplantation, a Pilot Study
NCT05622032 ·Status: COMPLETED
-
Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation
NCT07235501 ·Status: NOT_YET_RECRUITING
-
Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease
NCT02194439 ·Status: COMPLETED
-
Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702)
NCT03904134 ·Status: COMPLETED ·Phase: NA
-
Risk of Hepatitis B Reactivation After Bone Marrow Transplantation With Prior Hepatitis B Virus (HBV) Exposure
NCT01481649 ·Status: COMPLETED
-
Prevalence of Chronic Oral Graft Versus Host Disease Risk Factors in Pediatric Patients
NCT03880214 ·Status: UNKNOWN
-
Autologous Hematopoietic Stem Cell Transplantation for Allogeneic Organ Transplant Tolerance
NCT02549586 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study to Enable Process Validation of Commercial Grade OTL-101
NCT04140539 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
TCR Alpha/Beta and CD19-deplete Haplo-HSCT
NCT05288595 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Prospective Registry of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS).
NCT05090345 ·Status: RECRUITING
-
Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant
NCT00898612 ·Status: WITHDRAWN
-
Pediatric -Adult Care Transition Program of Patients With Sickle Cell Disease
NCT03786549 ·Status: RECRUITING ·Phase: NA